Zura Bio (ZURA) Operating Expenses (2022 - 2026)

Zura Bio's Operating Expenses history runs 5 years deep, the most recent figure standing at $25.5 million for Q1 2026.

• On a quarterly basis, Operating Expenses rose 32.43% year-over-year to $25.5 million in Q1 2026; TTM through Mar 2026 was $81.5 million, a 23.35% increase from a year earlier, with the FY2025 full-year figure at $75.2 million, up 36.34% from the prior year.
• Operating Expenses grew to $25.5 million in Q1 2026 per ZURA's latest filing, from $18.4 million in the prior quarter.
• Across five years, Operating Expenses topped out at $33.9 million in Q2 2023 and bottomed at $927000.0 in Q2 2022.
• The 5-year median for Operating Expenses is $15.7 million (2024), against an average of $14.5 million.
• Across the five-year window, Operating Expenses jumped 3557.5% in 2023 and tumbled 65.32% in 2024, its largest moves.
• Year by year, Operating Expenses stood at $17.3 million in 2022, then sank by 37.59% to $10.8 million in 2023, then soared by 45.3% to $15.7 million in 2024, then climbed by 17.03% to $18.4 million in 2025, then soared by 38.5% to $25.5 million in 2026.
• Per Business Quant, the three latest ZURA Operating Expenses figures stand at $25.5 million (Q1 2026), $18.4 million (Q4 2025), and $19.5 million (Q3 2025).